The estimated Net Worth of Stanley W Iii Peters is at least $1.27 Million dollars as of 14 June 2024. Mr Peters owns over 4,000 units of Conmed stock worth over $298,102 and over the last 10 years he sold CNMD stock worth over $355,819. In addition, he makes $620,751 as VP & GM of U.S. Advanced Surgical at Conmed.
Sign up
Mr III CNMD stock SEC Form 4 insiders trading
Mr has made over 23 trades of the Conmed stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 4,000 units of CNMD stock worth $167,720 on 14 June 2024.
The largest trade he's ever made was exercising 14,000 units of Conmed stock on 4 November 2021 worth over $558,180. On average, Mr trades about 1,426 units every 67 days since 2015. As of 14 June 2024 he still owns at least 4,063 units of Conmed stock.
You can see the complete history of Mr Peters stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Stanley W. Peters III biography
Stanley W. Peters III is the VP & GM of U.S. Advanced Surgical at Conmed.
What is the salary of Mr III?
As the VP & GM of U.S. Advanced Surgical of Conmed, the total compensation of Mr III at Conmed is $620,751. There are 3 executives at Conmed getting paid more, with Curt R. Hartman having the highest compensation of $1,787,620.
How old is Mr III?
Mr III is 46, he's been the VP & GM of U.S. Advanced Surgical of Conmed since . There are 8 older and 1 younger executives at Conmed. The oldest executive at Conmed Corp. is David R. Murray, 73, who is the Pres of ConMed Electrosurgery.
What's Mr III's mailing address?
Stanley's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Insiders trading at Conmed
Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti und Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.
What does Conmed do?
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
What does Conmed's logo look like?
Complete history of Mr Peters stock trades at Conmed und Conmed
Conmed executives and stock owners
Conmed executives and other stock owners filed with the SEC include:
-
Curt R. Hartman,
Chairman, CEO & Pres -
Patrick J. Beyer,
Pres of International & Global Orthopedics -
Todd W. Garner,
Exec. VP & CFO -
Stanley W. Peters III,
VP & GM of U.S. Advanced Surgical -
John E. Kennedy,
Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service -
David R. Murray,
Pres of ConMed Electrosurgery -
Shanna L. Cotti-Osmanski,
Exec. VP of Information Technology & CIO -
Heather L. Cohen,
Exec. VP of HR -
Peter K. Shagory,
Exec. VP of Strategy & Corp. Devel. -
Daniel S. Jonas,
Exec. VP of Legal Affairs, Gen. Counsel & Sec. -
Charles Farkas,
Director -
Brian Concannon,
Director -
David M Bronson,
Director -
Martha Goldberg Aronson,
Director -
Nathan Folkert,
VP GM Orthopedics -
Peter K Shagory,
EVP, STRAT & CORP DEVT -
John L Workman,
Director -
Mark E Tryniski,
Director -
Jo Ann Golden,
Director -
John Jed Kennedy,
Group Executive Vice President -
Wilfredo Ruiz Caban,
EVP QA, RA and Operations -
Jerome J. Lande,
Director -
Dirk Kuyper,
Director -
Daniel S Jonas,
Special Counsel & Corp Secy -
Johonna Marie Pelletier,
Treasurer and VP, Tax -
Todd W Garner,
Executive Vice President & CFO -
La Verne H Council,
Director -
Terence M Berge,
VP-Corporate Controller -
Luke A Pomilio,
Vice President -
Barbara J Schwarzentraub,
Director -
William Matthews,
Director -
William Abraham,
SENIOR VICE PRESIDENT -
Stuart J Schwartz,
Director -
Mark D Snyder,
EVP Mfg. Operations & Supply -
Gregory Renard Jones,
Vice President-Corporate QA/RA -
Stephen Mandia,
Director -
Joseph G Darling,
President Conmed Linvatec -
Bruce Daniels,
Director -
David Allen Johnson,
VP - Global Operations -
Frank R Williams,
Vice President -
Jane E Metcalf,
VP Corp. Regulatory Affairs -
Thomas Acey,
Secretary/Treasurer -
Dennis M Werger,
Gen. Man. of CONMED Endo Tech -
John J Stotts,
VICE PRESIDENT -
Alexander Jones,
Vice President/Corporate Sales -
Gerald G Woodard,
PRESIDENT- LINVATEC -
David R Murray,
President - Electrosurgery -
Robert Remmell,
Director -
Robert D Jr Shallish,
Vice President/Finance/CFO -
Eugene Starr,
President/Electrosurgery -
Eugene R Corasanti,
Chairman of the Board and CEO -
Joseph J Corasanti,
President & CEO -
Curt R Hartman,
President, CEO and Chair -
Heather L Cohen,
EVP & Chief HR & Legal Officer -
John D. Ferrell,
Executive Vice President - HR -
Pat Beyer,
Chief Operating Officer -
Jaclyn Peterson,
VP of Mfg. & Adv. Engineering -
Edward A. Clifford,
VP Global Manufacturing -
Brent Lalomia,
Vice President QA and RA -
Stanley W Iii Peters,
President AS and AET